Genedrive PLC Notice of Preliminary Results (2372T)
October 11 2017 - 1:00AM
UK Regulatory
TIDMGDR
RNS Number : 2372T
Genedrive PLC
11 October 2017
RNS
For release: 11 October 2017
genedrive plc ("genedrive" or the "Company")
Notice of Preliminary Results
genedrive plc (LSE: GDR), the molecular diagnostics company,
will be announcing its preliminary results for the twelve months
ending 30 June 2017 on Tuesday 17 October, 2017.
David Budd, Chief Executive Officer, and Matthew Fowler, Chief
Financial Officer, will host a presentation and simultaneous live
conference call for analysts, followed by a Q&A session, at
11:00am on the day of the results. The presentation will be held at
85 Gresham Street, London, EC2R 7HE.
- Ends -
For further details please contact:
genedrive plc
David Budd: CEO +44 (0)161 989 0245
Matthew Fowler: Finance Director
Peel Hunt LLP
James Steel
+44 (0)207 418 8900
Oliver Jackson
Consilium Strategic Communications
Chris Gardner +44 (0)203 709 5700
Matthew Neal
Laura Thornton
genedrive@consilium-comms.com
Notes to Editors
genedrive plc is a molecular diagnostics company developing and
commercialising a low cost, rapid, versatile, simple to use and
robust point of need molecular diagnostics platform for the
diagnosis of infectious diseases and for use in patient
stratification (genotyping), pathogen detection and other
indications. Further details can be found at: www.genedriveplc.com
and www.genedrive.com.
This information is provided by RNS
The company news service from the London Stock Exchange
END
NOROKKDNPBDDFKD
(END) Dow Jones Newswires
October 11, 2017 02:00 ET (06:00 GMT)
Genedrive (LSE:GDR)
Historical Stock Chart
From Apr 2024 to May 2024
Genedrive (LSE:GDR)
Historical Stock Chart
From May 2023 to May 2024